deltatrials
Completed PHASE4 NCT00412009

Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal

Investigation of a Novel Approach to Improve Adherence to Treatment and Treatment Success Rates for Tuberculosis Patients in Senegal

Sponsor: Institut de Recherche pour le Developpement

Conditions Tuberculosis
Interventions Comprehensive package of activities
Updated 4 times since 2017 Last updated: Dec 14, 2006 Started: May 31, 2003 Completion: Jan 31, 2005

A PHASE4 clinical study on Tuberculosis, this trial is completed. The trial is conducted by Institut de Recherche pour le Developpement and has accumulated 4 data snapshots since 2003. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE4

    First recorded

May 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut de Recherche pour le Developpement
Data source: Institut de Recherche pour le Developpement

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Dakar, Senegal